{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-072731","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2025-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.647650+00:00","generated_at":"2026-05-17T22:12:22.635212+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Select Medical Q2 revenue +4.5% to $1.34B, EPS $0.32, reaffirms FY2025 outlook","bullets":["Revenue $1,339.6M (+4.5% YoY); net income from continuing ops $57.9M (+53.8%).","Adjusted EBITDA $125.4M (+0.5% YoY); diluted EPS $0.32 vs $0.17 (+88.2%).","Rehab hospital revenue +17.2% to $313.8M; critical illness revenue -0.6% to $601.1M.","Reaffirms FY2025 revenue $5.3B-$5.5B, Adj EBITDA $510M-$530M, EPS $1.09-$1.19.","Declares $0.0625/share cash dividend (payable Aug 28); $1B buyback program ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-072731","json":"https://secwatch.observer/filing/0001104659-25-072731.json","markdown":"https://secwatch.observer/filing/0001104659-25-072731.md","text":"https://secwatch.observer/filing/0001104659-25-072731.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/0001104659-25-072731-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465925072731/tm2522098d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T22:12:22.635212+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}